Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$170.5K
350.00 shares
What this filing means
MALCOLM JAN plans to sell 350.00 shares of UNITED THERAPEUTICS CORP valued at approximately $170.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001950047-26-002072
350.00
Shares to sell
$170.5K
Approx. market value
50.00
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
6/26/2025
50.00Total acquired50.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/26/2025 | Restricted Stock Not Applicable | 50.00 | — |
| Total | 50.00 | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
50.00
Market value
$23.7K
2/17/2026
—Completed
Units to sell
50.00
Market value
$23.7K
2/3/2026
—Completed
Units to sell
50.00
Market value
$23.0K
1/20/2026
—Completed
Units to sell
50.00
Market value
$24.8K
1/6/2026
—Completed
Units to sell
50.00
Market value
$25.6K
12/23/2025
—Completed
Units to sell
50.00
Market value
$24.1K
12/11/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
50.00
Market value
$25.5K
3/3/2026
Total
Units
350.00
Value
$170.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/17/2026 | 50.00 | $23.7K | — | Completed |
2/3/2026 | 50.00 | $23.7K | — | Completed |
1/20/2026 | 50.00 | $23.0K | — | Completed |
1/6/2026 | 50.00 | $24.8K | — | Completed |
12/23/2025 | 50.00 | $25.6K | — | Completed |
12/11/2025 | 50.00 | $24.1K | — | Completed |
| Planned — Approximate Date | ||||
3/3/2026 | 50.00 | $25.5K | NASDAQ | Planned |
| Total | 350.00 | $170.5K | ||